Raymond James & Associates’s Nutrien NTR Stock Holding History

Raymond James & Associates’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$383K	Buy	+8,500	New	+$410K	﹤0.01%	3264
2022 Q1	–	Sell	-72,800	Closed	-$255K	–	4230
2021 Q4	$255K	Buy	72,800 +200	+0.3%	+$14K	﹤0.01%	3548
2021 Q3	$148K	Buy	72,600 +61,700	+566%	+$3.77M	﹤0.01%	3744
2021 Q2	$10K	Sell	10,900 -18,400	-63%	-$1.09M	﹤0.01%	4033
2021 Q1	$12K	Sell	29,300 -7,400	-20%	-$402K	﹤0.01%	3951
2020 Q4	$26K	Buy	+36,700	New	+$1.62M	﹤0.01%	3673
2019 Q3	–	Sell	-12,400	Closed	-$6K	–	3684
2019 Q2	$6K	Buy	+12,400	New	+$647K	﹤0.01%	3603

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

SII

Silchester International Investors London, United Kingdom $62M AUM 14.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Raymond James & Associates's NTR Position: Q3 2024 in Review

Raymond James & Associates increased its Nutrien (NTR) stake by 11% in Q3 2024, buying an estimated $1.14M and bringing the position to 241,470 shares worth $11.6M. The position accounts for 0.01% of the portfolio, ranked #1137.

Raymond James & Associates first reported a position in NTR in Q1 2018 and has held it in 27 quarters since. The position peaked at $44.7M in Q3 2023. 600 funds tracked by Wall St. Rank hold NTR as of Q3 2024.

Raymond James & Associates held 241,470 shares of Nutrien worth $11.6M as of Q3 2024.
Raymond James & Associates bought 23,607 Nutrien shares in Q3 2024, an estimated $1.14M.
Nutrien made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1137 holding.
Raymond James & Associates first reported a position in Nutrien in Q1 2018 and has held it in 27 quarters since.
Raymond James & Associates's Nutrien position peaked at $44.7M in Q3 2023.
600 funds tracked by Wall St. Rank held Nutrien as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.